Dear mooers,
NIO $NIO Inc (NIO.US)$ Q4 earnings conference call is to release on Mar.24 afterhours. The company expanded its product portfolio, increased its production footprint, and widen its market reach efficiently and effectively in recent years. Particularly, NIO has beaten analysts' revenue estimation over the last three quarters. Will the situation continue? The upcoming earnings results can cause a lot of volatility...

$Ardelyx (ARDX.US)$ another tip for you guys, adding in position around here is great. low risk high reward. huathuat swing trade back to 3 buck easy

$BlackBerry (BB.US)$ Today up?

$BioNTech (BNTX.US)$ From a comprehensive perspective, BNTX will become the best-performing vaccine stock! With the European preference and the approval of children’s vaccines, sales will continue to remain high. If the injections are strengthened every year, the current valuation level can be maintained. BNTX has not won other approvals yet, and BNTX has made money in Japan. Although it is not as expensive as mRNA and has a slightly lower profit, its cooperation with PFE has high yields and seizes opportunities from vaccines of all ages, almost always the first. Get approval. The performance should be very good, and the subsequent sales are endless. Especially in developed countries, they are also mRNA vaccines, and they will occupy a larger market if they are cheap.

For beginners, placing an order sometimes can be a difficult task.
In this video, we will guide you on how to place a market/limit order. 
Follow us for more tutorials. 
For more guides, please refer to moomoo courses at  https://live.moomoo.com/college 
Have fun with your financial journey on moomoo!
  $AMC Entertainment (AMC.US)$   $Tesla (TSLA.US)$   $S&P 500 Index (.SPX.US)$   $SPDR S&P 500 ETF (SPY.US)$   $Nasdaq Composite Index (.IXIC.US)$